COVID-19病毒和宿主反应蛋白:病理生物学、管理、诊断和治疗的文献综述。

IF 1.1 4区 医学 Q4 VIROLOGY Acta virologica Pub Date : 2021-01-01 DOI:10.4149/av_2021_103
Ragheswari Rajaraman, Dhanina Yedida, SunilGowda Sunnaghatta Nagaraja, Ilakya Selvakumar, Pooja Ramakrishnan, Prakash Shankaran, Natesan Vasanthakumar, S Suma Mohan, Devipriya Nagarajan
{"title":"COVID-19病毒和宿主反应蛋白:病理生物学、管理、诊断和治疗的文献综述。","authors":"Ragheswari Rajaraman,&nbsp;Dhanina Yedida,&nbsp;SunilGowda Sunnaghatta Nagaraja,&nbsp;Ilakya Selvakumar,&nbsp;Pooja Ramakrishnan,&nbsp;Prakash Shankaran,&nbsp;Natesan Vasanthakumar,&nbsp;S Suma Mohan,&nbsp;Devipriya Nagarajan","doi":"10.4149/av_2021_103","DOIUrl":null,"url":null,"abstract":"<p><p>Coronavirus disease 2019 (COVID-19) is a severe acute respiratory syndrome caused by a novel strain of coronavirus (SARS-CoV-2) which was declared by WHO as a cause of global pandemic. By human-to-human transmission it caused severe damage to mankind with increased mortality rate worldwide. Coronavirus is a spherical enveloped virus with single stranded positive-sense RNA with a size of ~30 kilobases encoding various structural, non-structural and accessory proteins. The entry of coronavirus into the host cells is mediated by spike proteins. SARS-CoV-2 efficiently replicates in host cell and by evading immune surveillance, like innate and adaptive immune responses, in the host cells ultimately leads to increased virulence and disease outcome. In the current review, we highlighted the molecular insights of SARS-CoV-2 and its infection mechanism in the host cell via host-viral protein interactions based on currently available data up to 16thMay 2020 using various research literature databases. The diagnostics of SARS-CoV-2 is mainly done by RT-qPCR and serological tests. There is no effective treatment for COVID-19, however, few methods like plasma therapy and remdesivir treatment are reported to show promising results in improving patient's health and decreasing mortality rate. Keywords: SARS-CoV; spike protein; nucleocapsid; COVID-19; interferon.</p>","PeriodicalId":7205,"journal":{"name":"Acta virologica","volume":"65 1","pages":"10-26"},"PeriodicalIF":1.1000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Literature review on virus and host response proteins in COVID-19: pathobiology, management, diagnosis and treatment.\",\"authors\":\"Ragheswari Rajaraman,&nbsp;Dhanina Yedida,&nbsp;SunilGowda Sunnaghatta Nagaraja,&nbsp;Ilakya Selvakumar,&nbsp;Pooja Ramakrishnan,&nbsp;Prakash Shankaran,&nbsp;Natesan Vasanthakumar,&nbsp;S Suma Mohan,&nbsp;Devipriya Nagarajan\",\"doi\":\"10.4149/av_2021_103\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Coronavirus disease 2019 (COVID-19) is a severe acute respiratory syndrome caused by a novel strain of coronavirus (SARS-CoV-2) which was declared by WHO as a cause of global pandemic. By human-to-human transmission it caused severe damage to mankind with increased mortality rate worldwide. Coronavirus is a spherical enveloped virus with single stranded positive-sense RNA with a size of ~30 kilobases encoding various structural, non-structural and accessory proteins. The entry of coronavirus into the host cells is mediated by spike proteins. SARS-CoV-2 efficiently replicates in host cell and by evading immune surveillance, like innate and adaptive immune responses, in the host cells ultimately leads to increased virulence and disease outcome. In the current review, we highlighted the molecular insights of SARS-CoV-2 and its infection mechanism in the host cell via host-viral protein interactions based on currently available data up to 16thMay 2020 using various research literature databases. The diagnostics of SARS-CoV-2 is mainly done by RT-qPCR and serological tests. There is no effective treatment for COVID-19, however, few methods like plasma therapy and remdesivir treatment are reported to show promising results in improving patient's health and decreasing mortality rate. Keywords: SARS-CoV; spike protein; nucleocapsid; COVID-19; interferon.</p>\",\"PeriodicalId\":7205,\"journal\":{\"name\":\"Acta virologica\",\"volume\":\"65 1\",\"pages\":\"10-26\"},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta virologica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4149/av_2021_103\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"VIROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta virologica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4149/av_2021_103","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"VIROLOGY","Score":null,"Total":0}
引用次数: 2

摘要

2019冠状病毒病(COVID-19)是由世卫组织宣布为全球大流行病因的新型冠状病毒(SARS-CoV-2)株引起的严重急性呼吸系统综合征。通过人与人之间的传播,对人类造成了严重的危害,全球死亡率上升。冠状病毒是一种球形包膜病毒,其单链正义RNA的大小约为30千碱基,编码各种结构、非结构和辅助蛋白。冠状病毒进入宿主细胞是由刺突蛋白介导的。SARS-CoV-2在宿主细胞中有效复制,并通过逃避免疫监视,如先天和适应性免疫反应,最终导致宿主细胞中的毒力和疾病结局增加。在当前的综述中,我们基于截至2020年5月16日的现有数据,利用各种研究文献数据库,通过宿主-病毒蛋白相互作用,重点介绍了SARS-CoV-2的分子见解及其在宿主细胞中的感染机制。SARS-CoV-2的诊断主要通过RT-qPCR和血清学检测完成。目前还没有有效的治疗方法,但血浆治疗和瑞德西韦治疗等方法在改善患者健康和降低死亡率方面收效甚微。关键词:冠状;峰值蛋白质;核衣壳;COVID-19;干扰素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Literature review on virus and host response proteins in COVID-19: pathobiology, management, diagnosis and treatment.

Coronavirus disease 2019 (COVID-19) is a severe acute respiratory syndrome caused by a novel strain of coronavirus (SARS-CoV-2) which was declared by WHO as a cause of global pandemic. By human-to-human transmission it caused severe damage to mankind with increased mortality rate worldwide. Coronavirus is a spherical enveloped virus with single stranded positive-sense RNA with a size of ~30 kilobases encoding various structural, non-structural and accessory proteins. The entry of coronavirus into the host cells is mediated by spike proteins. SARS-CoV-2 efficiently replicates in host cell and by evading immune surveillance, like innate and adaptive immune responses, in the host cells ultimately leads to increased virulence and disease outcome. In the current review, we highlighted the molecular insights of SARS-CoV-2 and its infection mechanism in the host cell via host-viral protein interactions based on currently available data up to 16thMay 2020 using various research literature databases. The diagnostics of SARS-CoV-2 is mainly done by RT-qPCR and serological tests. There is no effective treatment for COVID-19, however, few methods like plasma therapy and remdesivir treatment are reported to show promising results in improving patient's health and decreasing mortality rate. Keywords: SARS-CoV; spike protein; nucleocapsid; COVID-19; interferon.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Acta virologica
Acta virologica 医学-病毒学
CiteScore
3.10
自引率
11.80%
发文量
43
审稿时长
>12 weeks
期刊介绍: Acta virologica is an international journal of predominantly molecular and cellular virology. Acta virologica aims to publish papers reporting original results of fundamental and applied research mainly on human, animal and plant viruses at cellular and molecular level. As a matter of tradition, also rickettsiae are included. Areas of interest are virus structure and morphology, molecular biology of virus-cell interactions, molecular genetics of viruses, pathogenesis of viral diseases, viral immunology, vaccines, antiviral drugs and viral diagnostics.
期刊最新文献
The interaction of influenza A virus RNA polymerase PA subunit with the human β-actin protein Construction of recombinant adenovirus-5 vector to prevent replication-competent adenovirus occurrence Virtual screening and molecular dynamics simulation to identify potential SARS-CoV-2 3CLpro inhibitors from a natural product compounds library The TRK-fused gene negatively regulates interferon signaling by inhibiting TBK1 phosphorylation during PPMV-1 infection Favipiravir and ivermectin show in vitro synergistic antiviral activity against SARS-CoV-2
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1